Responses
Scientific Abstracts
Oral Presentations
Abstract Session: Spondyloarthritis – clinical aspects and treatment
OP0167 A randomized, double-blind, phase 1 study demonstrates equivalence in pharmacokinetics, safety, and efficacy of CT-P13 and infliximab in patients with ankylosing spondylitis
Compose a Response to This Article
Other responses
No responses have been published for this article.